Comparison of the potency of newly developed and currently available oximes to reactivate nerve agent-inhibited acetylcholinesterase in vitro and in vivo.

Department of Toxicology, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic.
Chemico-Biological Interactions (Impact Factor: 2.97). 01/2006; 157-158:367-8. DOI: 10.1016/j.cbi.2005.10.054
Source: PubMed

ABSTRACT Reactivation potency of three newly developed oximes K027, K033 and K048 was tested using standard in vitro and in vivo reactivation tests. K027 and K048 seem to be efficacious reactivators of tabun-inhibited acetylcholinesterase. K033 is sufficient reactivator of cyclosarin-inhibited AChE. However, its potency is poor compared with current "gold standard" oxime HI-6.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Description of the simple HPLC method with UV detection for the identification of the acetylcholinesterase reactivator–HI‐6 is described. Two salts of HI‐6 (dichloride and dimethanesulfonate) were tested. Using this method 0.5 µM LOD was determined. Our method could be used in future as standard method for the evaluation of HI‐6 stability and purity.
    Analytical Letters 01/2007; 40(14):2783-2787. · 0.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Oximes are well known as acetylcholinesterase reactivators and are used in organophosphorus poisoning to reactivate inhibited acetylcholinesterase. Therapeutically available oximes, namely, pralidoxime (2-PAM), obidoxime, trimedoxime and Hagedorn oxime (HI-6), have no broad-spectrum activity against structurally different kinds of organophosphorus anticholinesterases. The widely used oxime, 2-PAM, is least effective. The focus of the review is to find an oxime that is broad spectrum and superior to the presently available oximes for the treatment of organophosphorus poisoning. Numerous oxime-based reactivators have been synthesized -in laboratories in Croatia, United States of America, Israel and most recently in Czech Republic. Some experimental oximes synthesized in Czech Republic and named as K-series of oximes have been found promising. Among them, K-27 and K-48 have higher or comparable efficacy to all available oximes though it is not effective against all organophosphorus (OP) nerve agents. They are also efficacious in pretreatment protocol for OP anticholinesterases. K-27 oxime is a promising candidate to replace therapeutically available oximes with respect to insecticide/pesticide organophosphorus poisoning. K27 and K48 may be candidates to replace the only approved pretreatment drug, pyridostigmine, in military combat medicine for OP nerve agent. Keywords: K-oximes, K-27 and K-48 oxime, Bispyridinium aldoxime, Acetylcholinesterase reactivators, OPC poisoning.
    Tropical Journal of Pharmaceutical Research 06/2011; 10(3):341-349. · 0.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The most toxic warfare agents called nerve agents (tabun, sarin, soman, cyclosarin, VX) affect the peripheral and central nervous systems and others specific systems and organs as well. The respiratory system reacts to nerve agent poisoning with salivation, bronhorrhea, bronhospasm and centrally determined arrest. In the same conditions cardio vascular system reacts with bradycardia or tachycardia, cardiac arrhythmia, hypertension or hypotension and circulatory failure. The currently available antidote treatment of nerve agent intoxication consists of anticholinergic drug (atropine) and oxime cholinesterase reactivator. The goal of this study was to evaluate the ability of two newly synthesized reactivators of cholinesterase (BT-03 and BT-05) combined with atropine to abolish or minimize the toxic effects of soman and tabun on respiration, heart rate and blood pressure in rats. The survival time and rate of survival were determined as well. The results obtained showed that BT-05 had very positive influence on the soman and tabun-induced changes in respiration, hurt rate and circulation. BT-03 was ineffective against soman but at the same time ensured survival of all tabun poisoned animals. The antidote efficacy of the new synthesized compounds was compared to those of well known oxime reactivators obidoxime and HI-6.
    Military medicine 01/2009; Supplement(LXI):32-37. · 0.77 Impact Factor